loading...| Preferred Name |
troglitazone |
|
| Synonyms |
5-{4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl)methoxy]benzyl}-1,3-thiazolidine-2,4-dione |
|
| Definitions |
This is any condition in which the main influencing factor is troglitazone, a hypoglycemic agent that was taken off the market due to hepatotoxicity issues. Troglitazone is also an antioxidant, a vasodilator agent, an anticonvulsant, an anticoagulant, an antineoplastic agent, and a long-chain-fatty-acid--CoA ligase inhibitor. |
|
| ID |
http://purl.obolibrary.org/obo/XCO_0001254 |
|
| created_by |
slaulederkind |
|
| creation_date |
2024-01-19T10:41:51Z |
|
| database_cross_reference |
CHEBI:9753 MESH:D000077288 PMID:32119089 |
|
| definition |
This is any condition in which the main influencing factor is troglitazone, a hypoglycemic agent that was taken off the market due to hepatotoxicity issues. Troglitazone is also an antioxidant, a vasodilator agent, an anticonvulsant, an anticoagulant, an antineoplastic agent, and a long-chain-fatty-acid--CoA ligase inhibitor. |
|
| has_exact_synonym |
5-{4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl)methoxy]benzyl}-1,3-thiazolidine-2,4-dione |
|
| has_obo_namespace |
experimental_condition_ontology |
|
| id |
XCO:0001254 |
|
| label |
troglitazone |
|
| notation |
XCO:0001254 |
|
| prefLabel |
troglitazone |
|
| treeView |
http://purl.obolibrary.org/obo/XCO_0000407 http://purl.obolibrary.org/obo/XCO_0000435 http://purl.obolibrary.org/obo/XCO_0000523 http://purl.obolibrary.org/obo/XCO_0000271 http://purl.obolibrary.org/obo/XCO_0001090 |
|
| subClassOf |
http://purl.obolibrary.org/obo/XCO_0000407 http://purl.obolibrary.org/obo/XCO_0000435 http://purl.obolibrary.org/obo/XCO_0000523 http://purl.obolibrary.org/obo/XCO_0000271 http://purl.obolibrary.org/obo/XCO_0001090 |